Efficacy of erythromycin for psoriasis vulgaris
✍ Scribed by M. Polat; N. Lenk; B. Yalcin; G. Gür; E. Tamer; F. Artuz; N. Alli
- Book ID
- 108694318
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 432 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0307-6938
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
This randomized 10-week study compared the efficacy of benzoyl peroxide 5%/erythromycin 3% gel with erythromycin 4%/zinc 1.2% solution in 72 acne vulgaris patients. Physician global evaluations were significantly more improved (P < or = 0.05) in the benzoyl peroxide 5%/erythromycin 3% gel treatment
The effect of a liposomal preparation of beta-methasone dipropionate (0.039%, BDP) has been compared to that of a commercial propylene glycol-gel containing 0.064% BDP in a double-blind, randomized, paired trial lasting 14 d in 10 patients with atopic eczema and 10 patients with psoriasis vulgaris.
Topical erythromycin is a standard regimen for inflammatory acne vulgaris because of its action against Propionibacterium aches. Changes in P. aches colonization are inducible by long-lasting changes of skin surface pH. Therefore, the influence of six erythromycin preparations with approximative pH